Author: Kanda, Tatsuo; Sasaki-Tanaka, Reina; Masuzaki, Ryota; Matsumoto, Naoki; Okamoto, Hiroaki; Moriyama, Mitsuhiko
Title: Knockdown of Mitogen-Activated Protein Kinase Kinase 3 Negatively Regulates Hepatitis A Virus Replication Cord-id: vkd6vc58 Document date: 2021_7_10
ID: vkd6vc58
Snippet: Zinc chloride is known to be effective in combatting hepatitis A virus (HAV) infection, and zinc ions seem to be especially involved in Toll-like receptor (TLR) signaling pathways. In the present study, we examined this involvement in human hepatoma cell lines using a human TLR signaling target RT-PCR array. We also observed that zinc chloride inhibited mitogen-activated protein kinase kinase 3 (MAP2K3) expression, which could downregulate HAV replication in human hepatocytes. It is possible tha
Document: Zinc chloride is known to be effective in combatting hepatitis A virus (HAV) infection, and zinc ions seem to be especially involved in Toll-like receptor (TLR) signaling pathways. In the present study, we examined this involvement in human hepatoma cell lines using a human TLR signaling target RT-PCR array. We also observed that zinc chloride inhibited mitogen-activated protein kinase kinase 3 (MAP2K3) expression, which could downregulate HAV replication in human hepatocytes. It is possible that zinc chloride may inhibit HAV replication in association with its inhibition of MAP2K3. In that regard, this study set out to determine whether MAP2K3 could be considered a modulating factor in the development of the HAV pathogen-associated molecular pattern (PAMP) and its triggering of interferon-β production. Because MAP2K3 seems to play a role in antiviral immunity against HAV infection, it is a promising target for drug development. The inhibition of MAP2K3 may also prevent HAV patients from developing a severe hepatitis A infection.
Search related documents:
Co phrase search for related documents- acid inducible and acute hepatitis: 1
- acid inducible gene and acute hepatitis: 1
- aclf chronic acute liver failure and acute hav infection: 1, 2
- aclf chronic acute liver failure and acute hepatitis: 1, 2, 3, 4, 5, 6
- aclf chronic acute liver failure and acute liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- aclf chronic acute liver failure and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- aclf chronic acute liver failure and liver disease patient: 1, 2
- aclf chronic acute liver failure and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- aclf chronic acute liver failure and liver fibrosis: 1
- actb actin beta and actin beta: 1, 2, 3, 4, 5, 6
- actin beta and lps induce: 1
- actin beta and lysis buffer: 1, 2
Co phrase search for related documents, hyperlinks ordered by date